Attention Investors
Kindly note the Change in PAY IN for BSE A/C No. : 1201250000000691 (CDSL), if you have an NSDL A/C, kindly use INTER DEPOSITORY SLIP. For assistance, please call OR contact: Mr. Dadu, 98339 89807 / 022-6145 1000.    |   Exchanges / Depository: Prevent Unauthorized Transactions in your Trading / Demat account --> Update your Mobile Numbers / email IDs with your Stock Brokers / Depository Participant. Receive alerts on your Registered Mobile / email IDs for trading account transactions and all debit and other important transactions in your demat account directly from Exchange / Depository on the same day ......................Issued in the interest of Investors."     |    KYC : "KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."     |    ASBA-IPO : "No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."
 ««+1  ««-1
 
 
Laurus Labs LtdIndustry : Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code:540222NSE Symbol: LAURUSLABSP/E(TTM):131.22
ISIN Demat:INE947Q01028Div & Yield %:0.15EPS(TTM):6.3
Book Value(Rs):84.5862053Market Cap ( Cr.):44606.21Face Value(Rs):2
    Change Company 
( In Cr)
ParticularsMar 2025Dec 2024Sep 2024Jun 2024
 Rs CrRs CrRs CrRs Cr
Gross Sales 1650.011265.191184.851116.93
Other Operating Income 0.000.000.000.00
Other Income  72.167.1211.899.30
Total Income 1722.171272.311196.741126.23
Total Expenditure  1255.181058.911003.02955.54
PBIDT 466.99213.40193.72170.69
Interest  48.6048.0244.6940.89
PBDT 418.39165.38149.03129.80
Depreciation 88.1988.6690.9491.00
Tax 82.0732.5421.9717.26
Fringe Benefit Tax 0.000.000.000.00
Deferred Tax -3.77-13.09-6.32-7.24
Reported Profit After Tax 251.9057.2742.4428.78
Extra-ordinary Items  0.000.000.000.00
Adjusted Profit After Extra-ordinary item 251.9057.2742.4428.78
     
EPS (Unit Curr.) 4.681.060.790.53
EPS (Adj) (Unit Curr.) 4.681.060.790.53
Calculated EPS (Unit Curr.) 4.671.060.790.53
Calculated EPS (Adj) (Unit Curr.) 4.671.060.790.53
Calculated EPS (Ann.) (Unit Curr.) 18.694.253.152.14
Calculated EPS (Adj) (Ann.) (Unit Curr.) 18.694.253.152.14
Book Value (Unit Curr.) 0.000.000.000.00
Dividend (%) 0.000.0020.000.00
Equity 107.85107.85107.83107.83
Reserve & Surplus 0.000.000.000.00
Face Value 2.002.002.002.00
     
Public Shareholding (No Of.Shares) 0.000.000.000.00
Public Shareholding (% in Equity) 0.000.000.000.00
     
Pledged/Encumbered - No. of Shares 0.000.000.000.00
Pledged/Encumbered - % in Total Promoters Holding 0.000.000.000.00
Pledged/Encumbered - % in Total Equity 0.000.000.000.00
     
Non Encumbered - No. of Shares 0.000.000.000.00
Non Encumbered - % in Total Promoters Holding 0.000.000.000.00
Non Encumbered - % in Total Equity 0.000.000.000.00
     
PBIDTM(%) 28.3016.8716.3515.28
PBDTM(%) 25.3613.0712.5811.62
PATM(%) 15.274.533.582.58